This ground-breaking research accomplishment will open new doors for research on neurodegenerative diseases like AMD.
RPB grantees provide expert insight on geographic atrophy and dry AMD as part of the "Lunch & Learn" series.
Join RPB and Apellis Pharmaceuticals for a virtual event on Feb. 25 to learn about cutting-edge research into geographic atrophy and dry AMD.
RPB grantees provide expert advice on dry AMD as part of the "Lunch & Learn" series.
RPB grantees provide expert advice on AMD as part of the "Lunch & Learn" series.
Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.
Four new grantees received the Catalyst Awards for Innovative Research Approaches for AMD.
RPB and AUPO announce the 2018 recipient of the award focused on age-related macular degeneration.
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.